These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33779853)

  • 1. A composite scaffold of Wharton's jelly and chondroitin sulphate loaded with human umbilical cord mesenchymal stem cells repairs articular cartilage defects in rat knee.
    Li Z; Bi Y; Wu Q; Chen C; Zhou L; Qi J; Xie D; Song H; Han Y; Qu P; Zhang K; Wu Y; Yin Q
    J Mater Sci Mater Med; 2021 Mar; 32(4):36. PubMed ID: 33779853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord Wharton's jelly mesenchymal stem cells combined with an acellular cartilage extracellular matrix scaffold improve cartilage repair compared with microfracture in a caprine model.
    Zhang Y; Liu S; Guo W; Wang M; Hao C; Gao S; Zhang X; Li X; Chen M; Jing X; Wang Z; Peng J; Lu S; Guo Q
    Osteoarthritis Cartilage; 2018 Jul; 26(7):954-965. PubMed ID: 29391278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility study on intact human umbilical cord Wharton's jelly as a scaffold for human autologous chondrocyte: In-vitro study.
    Muthuchamy M; Subramanian K; Padhiar C; Dhanraj AK; Desireddy S
    Int J Artif Organs; 2022 Nov; 45(11):936-944. PubMed ID: 35982588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.
    Liu S; Hou KD; Yuan M; Peng J; Zhang L; Sui X; Zhao B; Xu W; Wang A; Lu S; Guo Q
    J Biosci Bioeng; 2014 Feb; 117(2):229-235. PubMed ID: 23899897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro evaluation of chondrocytes combined with Wharton's jelly of human umbilical cord oriented scaffold].
    Lü H; Xu G; Gai Y; Chen L; Liu S; Zhao P; Lu S; Zhang L; Quanyi G; Yang J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Aug; 28(8):1017-22. PubMed ID: 25417319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hWJECM-Derived Oriented Scaffolds with Autologous Chondrocytes for Rabbit Cartilage Defect Repairing.
    Zhao P; Liu S; Bai Y; Lu S; Peng J; Zhang L; Huang J; Zhao B; Xu W; Guo Q
    Tissue Eng Part A; 2018 Jun; 24(11-12):905-914. PubMed ID: 29264993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cartilage Injury Repair by Human Umbilical Cord Wharton's Jelly/Hydrogel Combined with Chondrocyte.
    Yang J; Zhao Y; Fan L; Gao C; Liu X; Jing X; Zhang H; Huang Y; Guo R; Long C; Guo Q; Liu J
    Tissue Eng Part C Methods; 2023 Mar; 29(3):110-120. PubMed ID: 36921276
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteogenic differentiation of Wharton's jelly-derived mesenchymal stem cells cultured on WJ-scaffold through conventional signalling mechanism.
    Beiki B; Zeynali B; Taghiabadi E; Seyedjafari E; Kehtari M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1032-S1042. PubMed ID: 30449193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton's Jelly (WJ-MSCs).
    Lech W; Sarnowska A; Kuczynska Z; Dabrowski F; Figiel-Dabrowska A; Domanska-Janik K; Buzanska L; Zychowicz M
    Sci Rep; 2020 Oct; 10(1):16946. PubMed ID: 33037314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silk fibroin-chondroitin sulfate scaffold with immuno-inhibition property for articular cartilage repair.
    Zhou F; Zhang X; Cai D; Li J; Mu Q; Zhang W; Zhu S; Jiang Y; Shen W; Zhang S; Ouyang HW
    Acta Biomater; 2017 Nov; 63():64-75. PubMed ID: 28890259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored PVA/ECM scaffolds for cartilage regeneration.
    Stocco E; Barbon S; Dalzoppo D; Lora S; Sartore L; Folin M; Parnigotto PP; Grandi C
    Biomed Res Int; 2014; 2014():762189. PubMed ID: 25147814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-culture of hWJMSCs and pACs in double biomimetic ACECM oriented scaffold enhances mechanical properties and accelerates articular cartilage regeneration in a caprine model.
    Zhang Y; Hao C; Guo W; Peng X; Wang M; Yang Z; Li X; Zhang X; Chen M; Sui X; Peng J; Lu S; Liu S; Guo Q; Jiang Q
    Stem Cell Res Ther; 2020 May; 11(1):180. PubMed ID: 32430067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repair of Osteochondral Defects Using Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells in a Rabbit Model.
    Liu S; Jia Y; Yuan M; Guo W; Huang J; Zhao B; Peng J; Xu W; Lu S; Guo Q
    Biomed Res Int; 2017; 2017():8760383. PubMed ID: 28261617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord-derived Wharton's jelly for treatment of knee osteoarthritis: study protocol for a non-randomized, open-label, multi-center trial.
    Gupta A; Maffulli N; Rodriguez HC; Lee CE; Levy HJ; El-Amin SF
    J Orthop Surg Res; 2021 Feb; 16(1):143. PubMed ID: 33602286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and In Vitro Study of Tissue-Engineered Cartilage Scaffold Derived from Wharton's Jelly Extracellular Matrix.
    Xiao T; Guo W; Chen M; Hao C; Gao S; Huang J; Yuan Z; Zhang Y; Wang M; Li P; Peng J; Wang A; Wang Y; Sui X; Zhang L; Xu W; Lu S; Yin H; Yang J; Liu S; Guo Q
    Biomed Res Int; 2017; 2017():5839071. PubMed ID: 29214173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro differentiation of human umbilical cord mesenchymal stem cells (hUCMSCs), derived from Wharton's jelly, into choline acetyltransferase (ChAT)-positive cells.
    Zhang L; Tan X; Dong C; Zou L; Zhao H; Zhang X; Tian M; Jin G
    Int J Dev Neurosci; 2012 Oct; 30(6):471-7. PubMed ID: 22683696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decellularized Wharton's Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications.
    Jadalannagari S; Converse G; McFall C; Buse E; Filla M; Villar MT; Artigues A; Mellot AJ; Wang J; Detamore MS; Hopkins RA; Aljitawi OS
    PLoS One; 2017; 12(2):e0172098. PubMed ID: 28222169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.